Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
about
The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic reviewImmune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsHealth outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.Consensus Conference on Clinical Management of pediatric Atopic DermatitisThe Efficacy and Safety of Long-term Oral Cyclosporine Treatment for Patients with Atopic Dermatitis.Cyclosporin treatment of atopic dermatitis: is it really associated with infectious diseases?What are the most promising strategies for the therapeutic immunomodulation of allergic diseases?The effects of treatment on itch in atopic dermatitisAtopic and non-atopic eczema.Therapeutic concepts in clinical dermatology: cyclosporine A in immunomediated and other dermatoses.New treatments for atopic dermatitis.Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.The use of ciclosporin in psoriasis.Cyclosporin A treatment in severe childhood psoriasis.Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model.Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis.Pathways to managing atopic dermatitis: consensus from the expertsNew and emerging trends in the treatment of atopic dermatitis.Quality of life in clinical trials for children.Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.Evidence - based pharmacological treatment of atopic dermatitis: an expert opinion and new expectations.Retrospective review of relapse after systemic cyclosporine in children with atopic dermatitis.Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Advances in therapeutic strategies for the treatment of pruritus.Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.Review of Systemic Treatment Options for Adult Atopic Dermatitis.Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.Cyclosporine A for severe atopic dermatitis in children. efficacy and safety in a retrospective study of 63 patients.Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.Clinical experience with systemic cyclosporine A treatment in severe childhood psoriasis.Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects.Paradoxical normalization of blood pressure in a child with atopic dermatitis treated with cyclosporin.Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial.Effect of oral cyclosporin A in children with Staphylococcus aureus-colonized vs S aureus-infected severe atopic dermatitis.The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey.Good response of linear scleroderma in a child to ciclosporin.Leflunomide as a novel treatment option in severe atopic dermatitis.
P2860
Q24799973-0895C661-CBB9-4030-A40D-AE8FDAAE3E65Q26799532-79A997E4-9B18-4C3A-9CAC-97B3719E2D3DQ27691377-0A654E3C-7CAE-4DF4-BEE1-550D953E2C86Q28071974-227623F0-12F0-4814-A23E-58FCF7B82B87Q33904734-B0555401-8286-4BD9-A1F5-7D3DF17451C5Q33904765-65BA37D7-7D8D-4C0D-8245-45E1D1A4B79FQ34190563-190A3210-F51E-4799-A4B6-E0D0FA0D5E2BQ34336696-D98AB543-0212-4A17-8947-47AA1B88DE83Q34441292-387EF864-D96E-438E-81C4-684275E259A6Q34459474-41101D82-894F-4EF4-831F-E62557890F98Q34592295-018F594D-CD49-441E-AF8B-BFB2DB0ADC38Q35539576-49CDF47B-FFB3-4AE4-B9AD-A84A10BE6244Q36048469-2DA27C4B-6D11-4F0D-90E5-28E3FADC2DB2Q36374570-D68FEFDE-9931-4BBA-BA48-D6AE4162A596Q36534241-195AD70E-19E6-4180-B0DC-A434E40E0696Q36732908-BF51DD16-77F5-4FBA-856C-BC281F7584ACQ36797258-588AC97B-451C-44FE-BCE3-4FC4FCE4A2B8Q37258723-202A7F75-0FDE-4ECF-932C-C4A540FC9731Q37634335-1D7F771F-8826-426E-9CDC-0B53085BBA34Q37811975-8F11E54B-132F-4155-89EC-71B98D0178B8Q37936458-3F463C31-A2DF-405B-A784-620D0B060B67Q38027604-924B582A-F2E3-4067-88CF-B652D7D9722AQ38107270-474FC0ED-35AC-44C1-BC67-63BABFDDD314Q38202096-EE6E4AC5-BEE4-4535-864C-58E639D7E3C4Q38233591-3A764906-B147-469C-9305-D057230038B6Q38452688-C9153434-1715-4D0D-919A-CC23D7AFEE78Q38656850-DB526BCE-F335-41A0-8A6C-E0B231AFE702Q38807878-F59C913A-C4A8-4508-B95D-E7EF33482E2BQ38956008-1E322E33-BAB5-428A-823F-BCE7C0819D8AQ38988270-ED475F48-452B-4A90-A999-C6281EB9885EQ39023291-3BA9805E-9494-4F75-97CA-86671C6CA3EFQ39449840-B66754B9-D0EC-418E-A8F9-29B3FECC5665Q40228512-ABCEE3A1-3FD8-4196-89B8-806DAEC3F109Q42659490-84A43019-7642-4A0F-A509-CAA6F5ABFD55Q44051934-BAAA8772-51D0-4AFC-B037-86C0B0CCE701Q44326443-93B10D80-72FE-4A4E-B51F-5170A1D71511Q44326453-BB3742DE-854B-44A3-9575-F41BC9D029C0Q44380067-8E3623EA-5F08-492B-8174-A2352A57694DQ44852603-597E4D37-F890-4234-8643-768F3DFB2BA1Q44950244-BFC33B2C-2657-49C0-B427-72789C1E5804
P2860
Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Cyclosporin for severe childho ...... rse versus continuous therapy.
@en
Cyclosporin for severe childho ...... rse versus continuous therapy.
@nl
type
label
Cyclosporin for severe childho ...... rse versus continuous therapy.
@en
Cyclosporin for severe childho ...... rse versus continuous therapy.
@nl
prefLabel
Cyclosporin for severe childho ...... rse versus continuous therapy.
@en
Cyclosporin for severe childho ...... rse versus continuous therapy.
@nl
P2093
P2860
P50
P1476
Cyclosporin for severe childho ...... rse versus continuous therapy.
@en
P2093
Berth-Jones J
Graham-Brown RA
P2860
P356
10.1046/J.1365-2133.2000.03241.X
P407
P577
2000-01-01T00:00:00Z